Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 26, 2022 at 06:39 am EDT
Share
Autobio Diagnostics Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 1,031.15 million compared to CNY 817 million a year ago. Revenue was CNY 1,031.15 million compared to CNY 817 million a year ago. Net income was CNY 240.2 million compared to CNY 171.48 million a year ago. Basic earnings per share from continuing operations was CNY 0.41 compared to CNY 0.29 a year ago. Diluted earnings per share from continuing operations was CNY 0.41 compared to CNY 0.29 a year ago.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
